Health & Pharmaceuticals: Claim back costs on your innovative projects

Are you maximising your potential tax credits?

Is your business missing out on valuable R&D Tax Credits?

From the latest drugs and wellness products, through to cutting edge medical equipment and treatments delivered in hospitals, the Health and Pharmaceutical Sector is rife with innovation.However, despite the considerable costs involved with developing new medical equipment and products, many businesses involved in the supply and development chain of medical and pharmaceutical production are not taking advantage of the full tax relief that the government has made available to them.

Case Studies

Hear from our clients about how working with Leyton has helped them receive valuable financial benefits from the R&D Tax Credits scheme.

DestiNA Genomics

Destina Genomics is an early stage research and development company, based in Edinburgh. They use their unique, patented chemistry to accurately detect nucleic acid biomarkers in biological fluids.

Lingoing Ltd

Lingoing Ltd bring together deaf clients, agencies, commercial organisations and sign language interpreters so they can work together efficiently. They offer an array of services including…

Case Studies

Hear from our clients about how working with Leyton has helped them receive valuable financial benefits from the R&D Tax Credits scheme.

DestiNA Genomics

Destina Genomics is an early stage research and development company, based in Edinburgh. They use their unique, patented chemistry to accurately detect nucleic acid biomarkers in biological fluids.

Lingoing Ltd

Lingoing Ltd bring together deaf clients, agencies, commercial organisations and sign language interpreters so they can work together efficiently. They offer an array of services including…

Leyton In The News

Leyton has recently been featured in a variety of news outlets and publications in the Pharmaceutical sector.

Pharma Boardroom
3 Ways the UK’s Pharma Sector is Driving Innovation
Read more
The Pharma Letter
What the UK economy can learn from the pharmaceutical sector
Read more

Qualifying R&D activity:

R&D within this industry can be broadly identified as solutions or supporting activity to resolve a biological unknown or uncertainty. It can be virtually limitless, however some of the key areas we have identified as prime for R&D Tax Credits are: the development of software, new product testing and development (including the development of manufacturing processes and methodologies), challenging technical work, product modification and cost optimisation.